Lv4
578 积分 2022-09-07 加入
In vivo chimeric antigen receptor (CAR)-T cell therapy
13天前
已完结
Treatment of chronic obstructive pulmonary disease: current pipeline and new opportunities
13天前
已完结
Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications
13天前
已完结
Is addiction the next frontier for GLP-1 receptor agonists?
26天前
已完结
Targeting triglyceride-rich lipoproteins in cardiovascular disease
1个月前
已完结
Expanding targeted therapy for lung cancer
1个月前
已完结
The evolving landscape of RAS-targeted therapies
1个月前
已完结
Radiopharma pipeline builds ahead of key data
1个月前
已完结
ELOVL6 activity attenuation induces mutant KRAS degradation
1个月前
已完结
The tumour microenvironment in pancreatic cancer — new clinical challenges, but more opportunities
2个月前
已完结
皖公网安备34019202002308
